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Abstract 
Purpose: We assess the prevalence of overactive bladder (OAB) a n d   i t s   r i s k   f actors i n   a   m a l e  
urologic veterans population. Materials and Methods: Validated self-administered question-
naire was prospectively given. Results: Among 1086 patients, OAB was present in 75%, of 
which 48% had not been diagnosed/treated. T h e   r i s k   o f   O A B   i n c r e a s e d   w i t h   a g e .  OAB was 
not associated with BMI, smoking, race, diabetes, CHF, and COPD. Conclusions: The pre-
valence of OAB in this population is under-diagnosed and under-treated.  
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INTRODUCTION 
Recent  international  population  and 
non-population  studies  reported  overactive  bladder 
(OAB) in 10-1 7 %   o f   t h e   a d u l t   p o p u l a t i o n ,   d e p e n d i n g  
on sex.1,2,3,4 I n   t h e   U . S . ,   a   p o p u l a t i o n -based study re-
ported that 16.0% of men and 16.9% of women expe-
rienced OAB.5 No study has examined the prevalence 
o f   O A B   i n   t h e   u r o l o g i c   p o p u l a t i o n ,   w h i c h   i s   e x p e c t e d  
t o   b e   m u c h   h i g h e r .  Some studies have reported asso-
c i a t i o n   o f   O A B   w i t h   a g e   ( m e n   a n d   w o m e n ) ,   b o d y  
mass index - BMI (female), menopause (female), con-
stipation  (female),  episiotomy  (female),  and  beer 
consumption (men). 2, 6,7,8 
In this prospective cohort study, we assess the 
p r e v a l e n c e   o f   O A B   i n   u r o l o g i c   m a l e   v e t e r a n s   p o p u l a-
tion, the need for OAB screening, and risk factors for 
OAB. 
METHODS 
An  IRB-approved  self-administered  question-
n a i r e   o n   u r i n a r y   s y m p t o m s   w a s   g i v e n   t o   m a l e   p a-
tients  who  visited  the  general  urology  outpatient 
clinic  at  a  Veterans  Administration  hospital  in 
Brooklyn, NY. It included questions on lower urinary 
tract  symptoms  (LUTS)  with  0-5  point  scale  and  on 
quality  of  life  with  0-6  (best  to  worst)  point  scale 
(based  on  a  modified  validated  Overactive  Bladder 
8-question Screener (OAB-V8)9). Questions on LUTS 
included urinary frequency (2 questions), urgency (2), 
nocturia (1), incontinence (2) and emptying (1). The 
questionnaire  also  included  medical  and  surgical 
history,  demographic  data,  BMI,  medications  and 
visit diagnosis.  
OAB-V 8   t o t a l   s c o r e   t h a t   w a s   e q u a l   t o   o r   g r e a t e r  
t h a n   6   f o r   m e n   w a s   d e f i n e d   a s   O A B   p o s i t i v e .  Subse-
quent  questionnaires from the same patient were ex-
cluded.  
To determine the relationship between OAB and 
o t h e r   f a c t o r s   ( a g e ,   B M I ,   s m o k i n g ,   r a c e ,   d i a b e t e s ,  
hypertension,  congestive  heart  failure,  chronic  ob-
structive  pulmonary  disease,  diuretic  medications 
and hepatitis), covariates were first individually eva-
luated  using  the  chi-square test. Statistically signifi-
cant (p <   . 0 5 )   c o v a r i a t e s   w e r e   r e t a i n e d   f o r   o d d s   r a t i o  Int. J. Med. Sci. 2010, 7 
 
http://www.medsci.org 
392 
a n a l y s i s .   P a t i e n t s   w e r e   e x c l u d e d   f r o m   a   s p e c i f i c   a n a l-
y s i s   i f   t h e y   d i d   n o t   r e p o r t   o n   t h e   v a r i a b l e   t o   b e   a n a-
lyzed. Results are presented as odds ratio and 95% 
confidence  interval  (95%  CI)  10.  Statistical  analyses 
w e r e   p e r f o r m e d   u s i n g   S t a t a   8 . 2   ( S t a t a C o r p ,   C o l l e g e  
Station, TX). 
RESULTS 
Among  the  male  patients,  1086  completed  the 
questionnaire. Table 1 summarizes the demographic 
data.  Mean  age  was  68  years  old  (quartile  range: 
59-77). The major ethnicities were European American 
(44%), African American (37%) and Hispanic Ameri-
can (11%).  
 
Table 1. Demographics 
 
 
O A B   w a s   p r e s e n t   i n   7 5 % .  A m o n g   t h o s e   s u r v e y e d  
w i t h   O A B ,   4 8 %   h a d   n o t   b e e n   d i agnosed  with  or 
t r e a t e d   f o r   O A B ,   L U T S   o r   b e n i g n   p r o s t a t i c   h y p e r t r o-
phy (BPH). T h o s e   w i t h   O A B   h a d   a   w o r s e   q u a l i t y   o f  
life  score.  Mean  quality  of  life  score  for  those  with 
O A B   w a s   3 . 4   o f   6 ,   a n d   t h o s e   w i t h o u t   O A B   1 . 6 .  Fur-
thermore,  59%  reported  urge  incontinence, 76% ur-
gency, 90% frequency and 85% nocturia.  
T h e r e   w a s   n o   a s s o c i a t i o n   o f   O A B   w i t h   B M I  
(p=0.61),  smoking  (p=0.87),  race  (p=0.32),  diabetes 
(p=0.83),  hypertension  (p=0.10),  congestive  heart 
failure (p=0.74), chronic obstructive pulmonary dis-
ease (p=0.69), and diuretic medications (p=0.91). The 
r i s k   o f   O A B   i n c r e a s e d   w i t h   a g e :   4 9 %   i n   m e n   a g e d  
40-4 9   y e a r s   t o   7 9 %   i n   m e n   a g e d   7 0 -79 years (p<0.001, 
OR=3.9). Interestingly, there was a statistically signif-
icant association between OAB and hepatitis (p=0.03, 
OR=2.2). See Table 3. 
 
Table 2. Prevalence of OAB, LUTS and OAB subtypes. 
 
DISCUSSION 
The prevalence of OAB in men has been reported 
t o   b e   1 0 . 2 -16.0%. I t   i s   e x p e c t e d   t o   b e   m u c h   h i g h e r   i n  
the  urologic  setting  since  urinary  complaint  is  a 
common reason for urologic visit. Our study found 
that 75% of those surveyed, experienced OAB. This is 
almost  five  fold  higher  than  that  reported  for  the 
general  population.  Since  OAB  is  a  compilation  of 
lower  urinary  tract  symptoms,  the  prevalence  of 
LUTS should be higher. Irwin et al.2 in their 5-country 
population  study  reported  the  prevalence  of  any 
L U T S   t o   b e   6 2 . 5 %   w h ereas the prevalence of OAB to 
be 10.8%. Our study found that 95% reported urinary 
frequency  and  85%  nocturia.  The  increase  in  our 
study  is  consistent  with Irwin et al.’s epidemiologic 
study.  
A l t h o u g h   a   h i g h e r   p r e v a l e n c e   o f   O A B   i s   e x-
p e c t e d   i n   o u r   s t u d y   p o p u l a t i o n ,   t h e   i n c r e a s e   m a y   a l s o  
be compounded by variation in OAB definition. Most 
 
Characteristics, n (%) Male
Age, years number %
  <30 8 1%
  30-39 16 1%
  40-49 49 5%
  50-59 197 18%
  60-69 274 25%
  >70 504 46%
  Not stated 38 3%
Race
  African American 404 37%
  Hispanic 119 11%
  White 477 44%
  Asian 1 0.1%
  Other 10 1%
  Not stated 75 7%
Education
  Less than high school 71 7%
  High school graduate 614 60%
  Some college/college graduate 293 29%
  Graduate school 69 7%
  Not stated 39 4%
Body mass index (BMI, kg/m
2)
  <25 191 18%
  25-29.9 363 33%
  >30 335 31%
  Not stated 197 18%
History of smoking  
  Smoker 180 17%
  Ex-smoker (stopped >6 mths) 458 42%
  Never 251 23%
  Not stated 197 18%
Previous surgery
  Bladder surgery 28 3%
  Urinary leakage surgery 3 0.3%
  Prostate surgery (RRP) 40 4%
  Prostate surgery (non-RRP) 118 11%Int. J. Med. Sci. 2010, 7 
 
http://www.medsci.org 
393 
reported population studies had used the 2002 Inter-
national  Continence Society definition of OAB. Our 
study  is  based  on  a  validated  OAB  screener  ques-
tionnaire (OAB-V8). As with any screening tool, the 
s e n s i t i v i t y   s h o u l d   b e   h i g h   b u t   s p e c i f i c i t y   m a y   n o t   b e  
high. The  OAB-V8 questionnaire has only been vali-
dated  in  a  primary  care  setting. Validation in a high 
risk population is still pending. 
O u r   s t u d y   s h o w e d   t h a t   a m o n g   t h o s e   w i t h   O A B ,  
o n l y   5 2 %   h a d   b e e n   d i a g n o s e d   w i t h   o r   t r e a t e d   f o r  
urinary  symptoms  (OAB,  LUTS  and/or  BPH).  Fur-
t h e r m o r e ,   t h o s e   w i t h   O A B   h a d   a   w o r s e   q u a l i t y   o f   l i f e  
score. M e a n   q u a l i t y   o f   l i f e   s c o r e   f o r   t h o s e   w i t h   O A B  
w a s   3 . 4   o f   6 ,   a n d   t h o s e   w i t h o u t   O A B   1 . 6 .  Thus, the 
4 8 %   o f   m e n   w i t h   O A B   t h a t   are undiagnosed or un-
treated  may  benefit  from  better  detection  and  treat-
ment initiation. The OAB-V 8   q u e s t i o n n a i r e   i s   a   p o s s i-
ble effective and fast screening tool.  
O u r   s t u d y   a l s o   e x a m i n e d   t h e   r i s k   f a c t o r s   f o r  
OAB in men. We found that OAB increased with age: 
49% in men aged 40-49 years to 79% in men aged 
70-79 years (p<0.001, OR=3.9). This is consistent with 
previous epidemiologic studies. Our study also found 
an association between OAB and hepatitis (OR=2.2, 
p=0.03). It is uncertain how hepatitis relates to  OAB. 
As such additional epidemiologic studies are needed 
in this regard. Unlike previous studies by Teleman et 
al.8, we found n o   a s s o c i a t i o n   b e t w e e n   O A B   a n d   B M I .  
However, patients in that study were all female. We 
a l s o   f o u n d   n o   a s s o c i a t i o n   w i t h   s m o k i n g ,   r a c e ,   d i-
abetes, hypertension, congestive heart failure, chronic 
obstructive pulmonary disease, and diuretic medica-
tions.  
Table 3. Risk factors for OAB. 
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CONCLUSION  
The  prevalence  of  OAB  in  the  male  urologic 
veterans is almost five fold higher than that reported 
for the general population. OAB  is  under-diagnosed 
and under-treated. This patient population may ben-
efit from routine screening. Furthermore, our study 
s h o w s   t h a t   O A B   i s   a s s o c i a t e d   w i t h   a g e   a n d   a history 
of hepatitis. 
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